Cargando…
In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals
The current study was undertaken to investigate potential oncogenic functions of NanogP8, a tumor-specific retrogene homolog of Nanog (expressed in pluripotent cells), in transgenic animal models. To this end, human primary prostate tumor-derived NanogP8 was targeted to the cytokeratin 14 (K14) cell...
Autores principales: | Badeaux, Mark A, Jeter, Collene R, Gong, Shuai, Liu, Bigang, Suraneni, Mahipal V, Rundhaug, Joyce, Fischer, Susan M, Yang, Tao, Kusewitt, Donna, Tang, Dean G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841319/ https://www.ncbi.nlm.nih.gov/pubmed/23839044 http://dx.doi.org/10.4161/cc.25402 |
Ejemplares similares
-
Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model
por: Liu, Bigang, et al.
Publicado: (2017) -
Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species
por: Liu, Bigang, et al.
Publicado: (2014) -
NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation
por: Mikulenkova, Erika, et al.
Publicado: (2020) -
Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer
por: Suraneni, Mahipal V, et al.
Publicado: (2014) -
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011)